Continuing Medical Education
Is DAS a Profitable Score to Be Used for Rheumatoid Arthritis Patient Follow Up?
¿Es rentable la utilización del DAS en el seguimiento clínico de los pacientes con artritis reumatoide?
Patricia Moya Alvarado
, Ana Laiz
Unidad de Reumatología, Servicio de Medicina Interna, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Read
10323
Timeswas read the article
3214
Total PDF
7109
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 0 | 25 | 25 |
| 2025 6 | 12 | 44 | 56 |
| 2025 5 | 137 | 199 | 336 |
| 2025 4 | 113 | 26 | 139 |
| 2025 3 | 109 | 34 | 143 |
| 2025 2 | 105 | 36 | 141 |
| 2025 1 | 102 | 64 | 166 |
| 2024 12 | 57 | 39 | 96 |
| 2024 11 | 52 | 72 | 124 |
| 2024 10 | 64 | 30 | 94 |
| 2024 9 | 76 | 20 | 96 |
| 2024 8 | 65 | 43 | 108 |
| 2024 7 | 65 | 36 | 101 |
| 2024 6 | 62 | 44 | 106 |
| 2024 5 | 73 | 43 | 116 |
| 2024 4 | 52 | 25 | 77 |
| 2024 3 | 53 | 41 | 94 |
| 2024 2 | 65 | 32 | 97 |
| 2024 1 | 50 | 28 | 78 |
| 2023 12 | 43 | 41 | 84 |
| 2023 11 | 79 | 36 | 115 |
| 2023 10 | 77 | 38 | 115 |
| 2023 9 | 105 | 47 | 152 |
| 2023 8 | 54 | 19 | 73 |
| 2023 7 | 47 | 21 | 68 |
| 2023 6 | 47 | 30 | 77 |
| 2023 5 | 50 | 20 | 70 |
| 2023 4 | 47 | 10 | 57 |
| 2023 3 | 95 | 29 | 124 |
| 2023 2 | 72 | 32 | 104 |
| 2023 1 | 45 | 29 | 74 |
| 2022 12 | 84 | 33 | 117 |
| 2022 11 | 80 | 44 | 124 |
| 2022 10 | 56 | 36 | 92 |
| 2022 9 | 56 | 35 | 91 |
| 2022 8 | 53 | 32 | 85 |
| 2022 7 | 64 | 56 | 120 |
| 2022 6 | 76 | 64 | 140 |
| 2022 5 | 70 | 60 | 130 |
| 2022 4 | 72 | 53 | 125 |
| 2022 3 | 73 | 60 | 133 |
| 2022 2 | 78 | 65 | 143 |
| 2022 1 | 103 | 41 | 144 |
| 2021 12 | 56 | 60 | 116 |
| 2021 11 | 64 | 52 | 116 |
| 2021 10 | 100 | 66 | 166 |
| 2021 9 | 77 | 62 | 139 |
| 2021 8 | 84 | 51 | 135 |
| 2021 7 | 64 | 48 | 112 |
| 2021 6 | 64 | 35 | 99 |
| 2021 5 | 64 | 36 | 100 |
| 2021 4 | 132 | 128 | 260 |
| 2021 3 | 57 | 35 | 92 |
| 2021 2 | 36 | 26 | 62 |
| 2021 1 | 49 | 34 | 83 |
| 2020 12 | 30 | 25 | 55 |
| 2020 11 | 27 | 21 | 48 |
| 2020 10 | 13 | 12 | 25 |
| 2020 9 | 42 | 20 | 62 |
| 2020 8 | 26 | 28 | 54 |
| 2020 7 | 25 | 37 | 62 |
| 2020 6 | 45 | 20 | 65 |
| 2020 5 | 28 | 15 | 43 |
| 2020 4 | 21 | 18 | 39 |
| 2020 3 | 20 | 8 | 28 |
| 2020 1 | 4 | 0 | 4 |
| 2019 9 | 6 | 0 | 6 |
| 2019 6 | 2 | 0 | 2 |
| 2019 3 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 6 | 0 | 6 |
| 2018 4 | 51 | 9 | 60 |
| 2018 3 | 62 | 8 | 70 |
| 2018 2 | 26 | 6 | 32 |
| 2018 1 | 25 | 4 | 29 |
| 2017 12 | 40 | 8 | 48 |
| 2017 11 | 39 | 9 | 48 |
| 2017 10 | 37 | 6 | 43 |
| 2017 9 | 34 | 7 | 41 |
| 2017 8 | 30 | 8 | 38 |
| 2017 7 | 35 | 14 | 49 |
| 2017 6 | 58 | 16 | 74 |
| 2017 5 | 57 | 15 | 72 |
| 2017 4 | 46 | 9 | 55 |
| 2017 3 | 37 | 15 | 52 |
| 2017 2 | 45 | 7 | 52 |
| 2017 1 | 45 | 9 | 54 |
| 2016 12 | 73 | 10 | 83 |
| 2016 11 | 70 | 11 | 81 |
| 2016 10 | 88 | 7 | 95 |
| 2016 9 | 107 | 12 | 119 |
| 2016 8 | 70 | 7 | 77 |
| 2016 7 | 43 | 8 | 51 |
| 2016 6 | 3 | 7 | 10 |
| 2016 5 | 1 | 12 | 13 |
| 2016 4 | 1 | 1 | 2 |
| 2016 3 | 0 | 3 | 3 |
| 2015 12 | 2 | 0 | 2 |
| 2015 10 | 1 | 23 | 24 |
| 2015 9 | 0 | 23 | 23 |
| 2015 8 | 3 | 14 | 17 |
| 2015 7 | 27 | 9 | 36 |
| 2015 6 | 76 | 3 | 79 |
| 2015 5 | 62 | 7 | 69 |
| 2015 4 | 55 | 5 | 60 |
| 2015 3 | 89 | 4 | 93 |
| 2015 2 | 58 | 5 | 63 |
| 2015 1 | 57 | 7 | 64 |
| 2014 12 | 87 | 8 | 95 |
| 2014 11 | 54 | 11 | 65 |
| 2014 10 | 82 | 10 | 92 |
| 2014 9 | 61 | 12 | 73 |
| 2014 8 | 58 | 15 | 73 |
| 2014 7 | 73 | 8 | 81 |
| 2014 6 | 80 | 12 | 92 |
| 2014 5 | 77 | 13 | 90 |
| 2014 4 | 64 | 9 | 73 |
| 2014 3 | 71 | 14 | 85 |
| 2014 2 | 52 | 11 | 63 |
| 2014 1 | 57 | 5 | 62 |
| 2013 12 | 35 | 6 | 41 |
| 2013 11 | 40 | 8 | 48 |
| 2013 10 | 56 | 5 | 61 |
| 2013 9 | 64 | 7 | 71 |
| 2013 8 | 49 | 9 | 58 |
| 2013 7 | 45 | 8 | 53 |
| 2013 6 | 37 | 9 | 46 |
| 2013 5 | 37 | 6 | 43 |
| 2013 4 | 35 | 13 | 48 |
| 2013 3 | 36 | 8 | 44 |
| 2013 2 | 25 | 8 | 33 |
| 2013 1 | 39 | 5 | 44 |
| 2012 12 | 33 | 5 | 38 |
| 2012 11 | 28 | 8 | 36 |
| 2012 10 | 15 | 2 | 17 |
| 2012 9 | 9 | 2 | 11 |
| 2012 7 | 1 | 0 | 1 |
| 2012 6 | 6 | 0 | 6 |
| 2012 5 | 2 | 0 | 2 |
| 2012 4 | 7 | 0 | 7 |
| 2012 3 | 9 | 0 | 9 |
| 2012 2 | 7 | 0 | 7 |
| 2012 1 | 5 | 0 | 5 |
| 2011 12 | 19 | 0 | 19 |
| 2011 11 | 9 | 0 | 9 |
| 2011 10 | 9 | 0 | 9 |
Show all
